Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Example Input: The Antarctic Sabbatical , as the travel company is dubbing it, will give five people the opportunity to study how widely micro plastics have infiltrated the region. Over a month’s time in December, they’ll be trained in lab work in Chile, collect snow samples in Antarctica, climb key glaciers and even visit the South Pole. Scientist Kirstie Jones-Williams, who will be helping to train and guide the volunteer researchers, says the goal of the program isn’t to create more scientists, but moreso global ambassadors on the dangers of pollution and more. “The science itself that we’re doing isn’t enough,” she told The Associated Press in a recent interview. “Actually, one of the biggest threats to our sort of natural environment isn’t necessarily the lack of information that we have ... but it’s more the disenfranchisement that can occur with policymakers and apathy and eco-fatigue. “One of the main things is to get a bunch of people that can take the messages that we learn back to their respective countries,” she said. It’s the second offering in Airbnb’s sabbatical program, which offers its users a chance to take time to do more than see the sights but actually do some good. Earlier this year, Airbnb selected five people to spend three months in Grottole in southern Italy to help preserve the way of life in the town, which is in danger of disappearing. Airbnb’s Chris Lehane says both sabbaticals are part of the company’s larger goal of more eco-friendly travel and to raise awareness of tourism’s global footprint. “Airbnb is not going to solve climate change, but we all have a responsibility to do what we can and use our capacity to help take steps forward,” said Lehane, senior vice president of global policy and communications. “A lot of travel in the world takes place in and around big events,” he said. “Can we find ways when people are going to travel around these big events, to make them much more sustainable?” No scientific background is required to be selected for the Antarctic trip: However, a love of the environment and the ability to complete some of the physical tasks, such as collecting samples, climbing glaciers and enduring bitter cold, is paramount. “It is hard to work in cold environments so people that ... perhaps work well under pressure, work well when they’re tired, that’s actually quite key,” Jones-Williams said,” and to actually ask questions, and people that are really hungry to get as much as they can out of this experience. “It’s really people that kind of respect the scientific process,” she added. The five will stay in Airbnb’s in Chile for their training for about two weeks and will stay at a camp provided by Antarctic Logistics & Expeditions in Antarctica for about a week or so. Airbnb will partner with Ocean Conservancy to use the research for advocacy. Nick Mallos, a conservation biologist and ocean debris specialist for Ocean Conservancy, called it an “incredible opportunity,” and noted that the group has long worked with “citizen science volunteers” to help clean up the environment. “We’ve seen the power of when you train and empower individuals to perform science, they can generate invaluable information and data that ultimately then can form solutions,” he said. ___ Online: http://airbnb.com/sabbatical
Example Output: Airbnb to train volunteers for science research sabbatical.

Example Input: Pakistan is also the only polio-endemic country in the world where polio cases rose from 2012 to 2013, the statement said. There were 91 cases last year but only 58 the year before. Polio can permanently paralyze or kill victims within hours of infection. Intensive vaccination campaigns have almost eradicated the disease worldwide, but it remains endemic in Pakistan, Afghanistan and Nigeria. In Pakistan, Taliban commanders have forbidden vaccination teams access in some areas. A handful of religious leaders have also denounced the campaign as a plot to sterilize Muslim children. The rhetoric has fueled violence against the vaccination teams. Many teams travel only with police protection. Last year there were more than 30 attacks on polio teams. But Dr. Elias Durry, the head of the WHO’s polio eradication program in Pakistan, emphasized that campaigns in most parts of the country had been successful. “The virus has not been seen in all parts of Pakistan,” he said. “It’s in very limited areas that we have problems in accessing.”  Some of the attacks took place in Peshawar, the capital of northern Khyber Paktunkhwa province. The old city is a maze of shops and homes where open sewers run through the streets. The city is plagued by Taliban and sectarian violence. Many families fleeing the Taliban insurgency in the north seek refuge there. Peshawar’s huge, mobile population and poor sanitation make it an ideal incubating ground for the disease. More than 90 percent of Pakistani polio cases last year were linked to a strain of disease found in the Peshawar sewers. All but one of the 13 cases in Afghanistan were also linked to Peshawar, WHO said.
Example Output: Pakistani city is world's biggest reservoir of polio viruses.

Example Input: Those ideas would represent tangible change and they have a realistic chance of being enacted. But it’s not like calling for Medicare to negotiate drug prices. Skeptics say the overall approach is underwhelming, and Trump risks being seen as an ally of the powerful pharmaceutical industry, not its disrupter. The White House Council of Economic Advisers has released a 30-page strategy for reducing drug costs, and it calls current policies “neither wise nor just.” The plan, outlined before Trump releases his new budget proposal Monday, focuses mainly on Medicare and Medicaid changes, along with ideas for speeding drug approvals and fostering competition. “Despite promises to drastically lower prices the mix of proposed changes does not appear likely to do so, even though there are some constructive proposals,” said John Rother, CEO of the National Coalition on Health Care, an advocacy group whose members include consumer organizations, medical societies, hospitals and insurers. Polls show the high cost of drugs is a top concern of Americans, regardless of political leanings. In his State of the Union speech, Trump seemed to foreshadow major change, saying “fixing the injustice of high drug prices” is a top priority this year. “And prices will come down substantially,” Trump added. “Watch.” As a candidate, Trump advocated Medicare negotiations and he called for allowing consumers to import lower-priced medicines from abroad. But the White House strategy paper veers away from such dramatic steps. His new health secretary, Alex Azar, was a top executive at pharmaceutical giant Eli Lilly. Medicare negotiations and drug importation are unacceptable to the drug industry, which has spent tens of millions of dollars since Trump’s inauguration to influence the Washington conversation around drug prices, including a high-profile TV advertising campaign portraying its scientists as medical trailblazers. The White House strategy largely sidesteps the question of whether drugmakers set their prices too high to start with. Rather, it recommends changes to policies that the administration believes unwittingly lead to higher prices, and suggests ways to speed drugs to market and increase competition. It takes aim at foreign governments that dictate what drug companies can charge their own citizens. Trump often has noted that the same medications Americans struggle to pay for can be bought for much less abroad. The White House report examined 35 economically advanced countries, and found that U.S. consumers and taxpayers pay for more than 70 percent of drug company profits that fund innovation. “Other nations are free-riding, or taking unfair advantage,” according to the review. The industry defends its pricing by saying companies have to recoup considerable research and drug development costs within the limited window when brand drugs are protected from generic competition. But examples of profit-seeking abound. An investigation by Sens. Charles Grassley, R-Iowa, and Ron Wyden, D-Ore., in 2015 found that the makers of the breakthrough hepatitis C drug Sovaldi decided to charge roughly $1,000 per pill even though the company’s own analysis showed a lower price would allow more patients to be treated. Gilead Sciences disagreed with the senators’ conclusion that it put profits before patients. The White House strategy recommends: —working with states to revise Medicaid rules so manufacturers don’t have an incentive to set artificially high prices due to the rebates they provide the program for low-income people. —changing the way Medicare pays for drugs administered in a doctor’s office so Medicare doesn’t reimburse based on a fixed percentage of a drug’s cost. Critics say the current system creates an incentive for doctors to prescribe more expensive medications. The Obama administration proposed a similar change, but had to back off. —changing a requirement that insurers in Medicare’s prescription program cover at least two different medications in each broad class of drugs. In some cases, that can tie the hands of insurers trying to negotiate lower prices. —requiring insurers to share rebates from drug companies with patients. Drugmakers use the rebates to help gain market share. Insurers say they plow the money into reducing premiums. But patient copayments are usually based on the full price of the drug, before rebates. The issue is a major source of friction between drug companies and insurers. —revising the Food and Drug Administration’s drug review and approval process to promote competition. Many of the ideas can be pursued by the administration through rule-making, which means Trump can drive change without a balky Congress. But whether that translates into a big hit with the public is unclear. There’s no estimate from the White House of the potential impact on prices. Financial analyst and former drug company executive Richard Evans said the administration plan would help bring down costs, but not to the same degree as giving Medicare a direct role in setting prices. “Convincing the average voter who is upset about drug prices that this is the path to righteousness is going to be a hard sell,” Evans said.
Example Output:
On drug costs, modest steps follow Trump’s big promises.